Loading organizations...
Trial Library provides an AI-powered solution for recruitment and retention in oncology clinical trials. The company’s platform leverages artificial intelligence to streamline discovery and access of cancer precision medicine trials. Its integrated system offers tools for internal referral optimization, patient recruitment, and trial navigation, connecting a growing network of healthcare providers and clinics.
The company was established to address significant barriers in clinical trial access. Its founders recognized that diverse research environments are critical for broad medical advancements, believing technology can sustainably disseminate high-quality health information. This insight drives its mission to creatively overcome participation challenges.
Trial Library serves patients, healthcare providers, and pharmaceutical sponsors, creating a seamless connection to oncology clinical trials. Its vision is to empower stakeholders, advancing health equity through expanded access to advanced cancer treatments and ultimately enhancing overall health outcomes.
Trial Library has raised $15.0M across 2 funding rounds.
Trial Library has raised $15.0M in total across 2 funding rounds.
Trial Library has raised $15.0M in total across 2 funding rounds.
Trial Library's investors include Lance Armstrong, Allison Baum Gates, Civilization Ventures, How Women Invest, Lux Capital, Overwater Ventures, Cris De Luca, 7wire Ventures, Frederique Dame, Ingeborg Investments, Maveron, McCarthy Capital.
Trial Library is an AI-enabled health technology company that builds tools to increase access to oncology clinical trials by connecting patients, community providers, payers and sponsors with trial opportunities and navigation support[1][2].
High‑Level Overview
Origin Story
Core Differentiators
Role in the Broader Tech & Healthcare Landscape
Quick Take & Future Outlook
If you’d like, I can:
Trial Library has raised $15.0M across 2 funding rounds. Most recently, it raised $10.0M Series A in December 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Dec 2, 2025 | $10M Series A | Lance Armstrong, Allison Baum Gates | Civilization Ventures, HOW Women Invest, LUX Capital, Overwater Ventures, Cris DE Luca | Announced |
| Aug 1, 2022 | $5M Seed | LUX Capital | 7wire Ventures, Frederique Dame, Ingeborg Investments, Maveron, McCarthy Capital, Next Ventures, OMERS Ventures, RED Swan Ventures, SuperAngel.Fund, The Food Loft, Tiffany, Town Hall Ventures, XFactor Ventures, Alison Pincus, Brian Sugar, Elliott Cohen, Henry Davis, Jason Starr, JON Stein, LEV Ekster, NIK Sharma, Julian Eison, Ivor Horn | Announced |